翰宇药业
(300199)
| 流通市值：132.22亿 | | | 总市值：165.34亿 |
| 流通股本：7.06亿 | | | 总股本：8.83亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 58,441,523.45 | 94,865,082.92 | 137,761,180.37 | 73,829,807.63 |
| 应收票据及应收账款 | 168,545,933.78 | 99,059,120.31 | 101,053,348.1 | 128,224,859.33 |
| 其中：应收票据 | 1,983,064.5 | 3,285,587.08 | 2,167,402.65 | 325,800 |
| 应收账款 | 166,562,869.28 | 95,773,533.23 | 98,885,945.45 | 127,899,059.33 |
| 应收款项融资 | 4,138,217.86 | 813,510 | 1,493,414.8 | 528,344.8 |
| 预付款项 | 7,249,038.88 | 6,320,217.4 | 9,018,493.96 | 12,117,410.55 |
| 其他应收款合计 | 6,091,893.8 | 5,024,074.07 | 9,305,934.67 | 9,820,808.62 |
| 存货 | 225,749,209.48 | 238,630,347.88 | 250,198,043.27 | 200,478,416.84 |
| 其他流动资产 | 23,300,629.1 | 17,229,459.49 | 39,201,605.53 | 27,438,532.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 494,618,808.48 | 463,048,006.84 | 548,032,020.7 | 452,438,180.12 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,959,648.14 | 2,376,307.12 | 3,466,920.56 | 3,728,852.02 |
| 其他权益工具投资 | 5,676,463.22 | 5,676,463.22 | 5,768,123.54 | 5,768,123.54 |
| 其他非流动金融资产 | - | 2,569,087.79 | 18,921,599.13 | 19,244,006.72 |
| 投资性房地产 | 241,924,217.58 | 243,709,163.26 | 243,612,791.07 | 245,385,892.83 |
| 固定资产 | 1,613,060,858.08 | 1,636,454,216.19 | 1,600,944,832.29 | 1,619,293,951.2 |
| 在建工程 | 39,424,325.56 | 37,105,016.01 | 107,153,608.46 | 82,171,845.64 |
| 使用权资产 | 607,962.04 | 818,057.59 | 181,207.88 | 405,041.5 |
| 无形资产 | 286,486,616.98 | 293,414,653.7 | 308,379,158.3 | 297,894,030.05 |
| 开发支出 | 142,685,817.52 | 136,673,090.93 | 117,003,995.11 | 130,867,765.61 |
| 长期待摊费用 | 23,489,507.64 | 24,679,017.72 | 14,296,168.19 | 13,627,041.28 |
| 递延所得税资产 | 42,992,037.16 | 43,761,673.29 | 42,662,674.26 | 41,778,332.87 |
| 其他非流动资产 | 145,119,308.3 | 117,940,886.43 | 106,695,665.05 | 117,199,760.05 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,543,426,762.22 | 2,545,177,633.25 | 2,569,086,743.84 | 2,577,364,643.31 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,038,045,570.7 | 3,008,225,640.09 | 3,117,118,764.54 | 3,029,802,823.43 |
| 流动负债: | | | | |
| 短期借款 | 634,616,058.33 | 638,994,477.64 | 546,176,215.4 | 435,080,606.25 |
| 应付票据及应付账款 | 231,803,740.1 | 218,259,435.21 | 167,786,904.91 | 140,753,553.83 |
| 其中：应付票据 | 0.55 | 0.55 | - | - |
| 应付账款 | 231,803,739.55 | 218,259,434.66 | 167,786,904.91 | 140,753,553.83 |
| 预收款项 | 8,514,798.82 | 6,578,841.77 | 4,410,098.63 | 4,305,034.41 |
| 合同负债 | 82,878,785.91 | 124,478,071.04 | 70,861,771.52 | 53,774,506.62 |
| 应付职工薪酬 | 11,114,509.96 | 28,020,539.27 | 28,230,789.71 | 27,730,921.6 |
| 应交税费 | 10,390,397.77 | 10,700,078.93 | 7,310,749.78 | 8,058,946.12 |
| 其他应付款合计 | 126,793,483.62 | 99,703,919.45 | 112,195,581.27 | 102,478,714.81 |
| 一年内到期的非流动负债 | 484,936,966.89 | 294,349,710.67 | 340,315,876.03 | 294,268,929.97 |
| 其他流动负债 | 950,116.46 | 3,468,094.67 | 8,357,131.75 | 6,530,108.74 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,591,998,857.86 | 1,424,553,168.65 | 1,285,645,119 | 1,072,981,322.35 |
| 非流动负债: | | | | |
| 长期借款 | 356,218,993 | 563,326,709.8 | 664,011,254.8 | 754,695,799.8 |
| 应付债券 | 298,023,863.77 | 297,748,970.02 | 297,488,427.01 | 297,227,884 |
| 租赁负债 | - | 0 | - | - |
| 长期应付款 | 3,500,000 | 3,500,000 | 3,500,000 | 3,500,000 |
| 预计负债 | 6,293,781.88 | 6,293,781.88 | 22,288,491.85 | 22,288,491.85 |
| 递延收益 | 103,991,484.27 | 106,913,012.82 | 108,757,350.43 | 94,118,270.63 |
| 递延所得税负债 | 11,632,435.92 | 8,843,484.9 | 5,012,925.78 | 5,012,925.78 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 779,660,558.84 | 986,625,959.42 | 1,101,058,449.87 | 1,176,843,372.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,371,659,416.7 | 2,411,179,128.07 | 2,386,703,568.87 | 2,249,824,694.41 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 883,241,336 | 883,241,336 | 883,241,336 | 883,241,336 |
| 资本公积 | 1,447,838,319.1 | 1,447,838,319.1 | 1,447,129,451.52 | 1,468,434,185.72 |
| 其他综合收益 | 41,125,057.3 | 41,224,440.66 | 38,555,937.94 | 39,913,920.65 |
| 盈余公积 | 56,688,751.56 | 56,688,751.56 | 56,688,751.56 | 56,688,751.56 |
| 未分配利润 | -1,780,497,642.48 | -1,850,366,010.01 | -1,718,684,780.59 | -1,694,237,933.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 648,395,821.48 | 578,626,837.31 | 706,930,696.43 | 754,040,259.98 |
| 少数股东权益 | 17,990,332.52 | 18,419,674.71 | 23,484,499.24 | 25,937,869.04 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 666,386,154 | 597,046,512.02 | 730,415,195.67 | 779,978,129.02 |
| 负债和股东权益合计 | 3,038,045,570.7 | 3,008,225,640.09 | 3,117,118,764.54 | 3,029,802,823.43 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-30 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |